Actively Recruiting
Echocardiographic Analysis by Artificial Intelligence in Hypertension
Led by Hospices Civils de Lyon · Updated on 2024-11-08
200
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are developing artificial intelligence (AI) tools to analyze heart changes caused by arterial hypertension using routine echocardiography images combined with patient data. The goal is to better understand the range of heart effects in people with high blood pressure, especially in cases that are difficult to assess. This study aims to create automatic methods to measure heart function more precisely than current clinical approaches. The study involves patients who had blood pressure assessments during hospital stays at two cardiology centers between 2018 and 2021. Researchers will use clinical data such as blood pressure levels, the number of blood pressure medications, and NT-proBNP blood test results, which relate to heart pressure and muscle mass. This information will help guide the AI training and evaluate its performance in analyzing heart function. Participants' existing clinical data and echocardiography images will be analyzed by AI to identify detailed heart function markers. Researchers will focus on baseline measures including arterial blood pressure, the count of antihypertensive drugs, and NT-proBNP concentrations. The study does not involve new treatments, and participation consists of using existing medical records and imaging data to improve understanding of hypertension's impact on the heart.
CONDITIONS
Brief Title
Echocardiographic Analysis by Artificial Intelligence in Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent a comprehensive blood pressure assessment during hospitalization in the Cardiologic Federation at Croix Rousse Hospital and Lyon Sud Hospital between January 2018 and December 2021
- Adults aged 18 years or older
You will not qualify if you...
- Patients who are minors
- Patients under curatorship or guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - During hospitalization between January 2018 and December 2021
Participants undergo assessments including blood pressure measurement, antihypertensive medication count, and NT-proBNP concentration measurement to evaluate hypertension severity.
1 to 2 visits depending on assessments
Duration - Up to study completion in December 2024
Participants are observed based on collected data without additional intervention.
No scheduled visits; data collected from existing records
Trial Site Locations
Total: 1 location
1
Hopital Lyon Sud
Pierre-Bénite, France, 69310
Actively Recruiting
Research Team
P
PierreYves COURAND, MD
F
Fatou LANGEVIN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here